| 000 | 04562nam a2200409 i 4500 | ||
|---|---|---|---|
| 999 |
_c360969 _d360969 |
||
| 001 | 360969 | ||
| 003 | ES-MaUEC | ||
| 005 | 20230102121306.0 | ||
| 006 | a||||fo|||| 00| 0 | ||
| 007 | cr nn nnnaamaa | ||
| 008 | 210719s2021 gw a s |||| 0|eng d | ||
| 020 | _a9783030716974 | ||
| 024 | 7 |
_a10.1007/978-3-030-71697-4 _2doi |
|
| 040 |
_aES-MaUEC _bspa _cES-MaUEC _dES-MaUEC |
||
| 050 | 4 |
_aR853.B54 _b2021 EB |
|
| 245 | 0 | 0 |
_aIdentification of Biomarkers, New Treatments, and Vaccines for COVID-19 _cedited by Paul C. Guest |
| 250 | _aFirst edition 2021 | ||
| 264 | 1 |
_aCham _bSpringer International Publishing _c2021 |
|
| 264 | 4 | _c2019 | |
| 300 |
_a1 recurso en línea (IX, 234 páginas) _b28 ilustraciones, 24 ilustraciones a color |
||
| 336 |
_2rdacontent _aTexto _btxt |
||
| 337 |
_2rdamedia _aelectrónico _bc |
||
| 338 |
_2rdacarrier _arecurso electrónico _bcr |
||
| 490 | 0 |
_aProteomics, Metabolomics, Interactomics and Systems Biology _x2730-6216 _v1327 |
|
| 490 | 0 | _aBiomedical and Life Sciences (SpringerNature-11642) | |
| 490 | 0 | _aBiomedical and Life Sciences (R0) (SpringerNature-43708) | |
| 505 | 0 | _a1. Genetic Aspects and Immune Responses in Covid-19: Important Organ Involvement -- 2. Prevalence of COVID-19 and the Continued Citizen-based Control in Japan -- 3. COVID-19 Pandemicin Brazil: History, Characteristics, and Evolution -- 4. The Experiences of Recovered COVID-19 Patients in Baqiyatallah Hospital: A Qualitative Study -- 5. Age-specific Differences in the Severity of COVID-19 Between Children and Adults: Reality and Reasons -- 6. Sex differences and COVID-19 -- 7. Intestinal Microbiota in the Sars-Cov2 Infection: What is known? -- 8. SARS-CoV-2 Infection and the Kidneys: an Evolving Picture -- 9. Cutaneous Manifestations of COVID-19: Early Diagnosis and Prognostic Information -- 10. How do we Manage Breastfeeding during the COVID-19 Pandemic? -- 11. Deep Learning Analysis in Prediction of COVID-19 Infection Status using Chest CT Scan Features -- 12. Using Ozone Therapy as an Option for Treatment of COVID-19 Patients: A Scoping Review -- 13. COVID-19, Coenzyme Q10 and Selenium -- 14. Topical Oral and Intranasal Antiviral Agents for Coronavirus Disease 2019 (COVID-19) -- 15. Cinnamon: A Promising Natural Product against COVID-19 -- 16. Curcumin and Piperine in COVID-19: a Promising Duo to the Rescue -- 17. Association of in-hospital use of statins, aspirin and renin-angiotensin-aldosterone inhibitors with mortality and ICU admission due to COVID-19A -- 18. The Worldwide Effort to Develop Vaccines for COVID-19. | |
| 520 | 3 | _aThe novel coronavirus 2019 (COVID-19) has caused a serious global pandemic in just one year. Nearly every country and territory in the world has been affected by the virus. The virulence and infection rate of the virus are profound, and has required extreme social distancing measures across the globe in order to prevent overwhelming the healthcare services and hospitals. COVID-19 appears to have the greatest effects on elderly individuals and those who have co-morbid diseases, such as diabetes and obesity. As the cases and death rate remain high, there are justified fears of this virus remaining for several months or years to come. To address this, a rapid and unprecedented worldwide mobilization effort has begun to identify effective treatments and develop vaccines. As these begin to be deployed and administered across the globe, many now feel the virus will be brought under control and lives will eventually return to normal. This new volume will increase readers' understanding of the ongoing COVID-19 pandemic through a series of chapters that address these concerns. Leading experts will discuss new treatment approaches, vaccine development, mental health aspects of the pandemic, and convey the results of survey studies. The book will be an excellent resource for researchers studying virology, metabolic diseases, respiratory disorders, and clinical scientists, physicians, drug companies, and healthcare services and workers. . | |
| 988 | _aSpringer_BiomedLife_2021 | ||
| 650 | 7 |
_2embne _aMarcadores biológicos _9162047 |
|
| 700 | 1 |
_aGuest, Paul C. _eeditor literario _4edt _4http://id.loc.gov/vocabulary/relators/edt |
|
| 776 | 0 | 8 |
_iPrinted edition: _z9783030716967 |
| 776 | 0 | 8 |
_iPrinted edition: _z9783030716981 |
| 856 | 4 | 0 |
_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-030-71697-4 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid) |
| 942 |
_2lcc _cLE |
||
| 998 |
_b01/2022 _dz _ek _zSI |
||